acrux going gangbusters

  1. 461 Posts.
    bioshares reports that commercialisation forges ahead stating that acrux looks like one of the biotechs success stories with $34 million in the bank and profitability in sight.the evamist project is going very well and that the company has many approaches for ellavie(evamistin usa)in europe,japan,korea,south africa and canada.ellavie will be distributed in australia by aspen pharmacare.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.6¢
Change
0.000(0.00%)
Mkt cap ! $6.524M
Open High Low Value Volume
1.5¢ 1.6¢ 1.5¢ $9.887K 624.5K

Buyers (Bids)

No. Vol. Price($)
1 6355 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 20000 1
View Market Depth
Last trade - 15.00pm 26/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.